Galvani’s lead therapy utilizes splenic nerve stimulation to modulate the immune system for the treatment of Rheumatoid Arthritis. This innovative approach offers a novel pathway to manage the disease and improve patient outcomes. Currently enrolling patients in clinical studies within the US, Netherlands, and the UK.